Dr Titi Chen
Nephrologist and Transplant Physician, Westmead Hospital
Chronic kidney disease, acute kidney injury, glomerulonephritis, dialysis, hypertension, immunology, translational medicine.
Internal medicine, clinical and basic science.
Defining the role of kidney CD103+ dendritic cells in kidney disease for potential therapies
University of Sydney Medical School
Westmead Institute for Medical Research
Department of Renal Medicine, Westmead Hospital
AWARDS
Young Nephrologist Basic Science Award. Interntaionl Society of Nephrology World Congress of Nephrology 2019
Basic Science Award. Australian New Zealand Society of Nephrology Annual Scientific Conference 2018
Best abstract. Asian Pacific Congress of Nephrology. 2018
The Royal Australasian College of Physicians Jacquot Award for Research Excellence. 2017-2019
ACT Health Quality in Healthcare Award. 2008
SCHOLARSHIPS
National Health and Medical Research Council Postgraduate Scholarship. 2017-2019
Westmead Instititue for Medical Research, John&Anne Leece Family Grant. 2017-2019
Postgraduate Research Support, University of Sydney. 2017, 2018
Australian Postgraduate Awards. 2016
Jerry Koutts Research Scholarship, ICPMR Westmead. 2016
Australian Rotary Health Scholarship 2016
TRAVEL GRANTS (COMPETITIVE)
Travel Grant to World Congress of Nephrology (from International Society of Neprhology). 2019
Travel Grant to Asian Pacific Congress of Nephrology (from Asian Pacific Society of Nephrology). 2018
Travel Grant to Hong Kong Society of Nephrology Annual Conference (from Asian Pacific Society of Nephrology). 2017
Travel Grant to American Society of Nephrology Kidney Week (from Australian New Zealand Society of Nephrology). 2017
Travel Grant to Australian New Zealand Society of Nephrology Annual Scientific Meeting (from Australian New Zealand Society of Nephrology). 2017
Travel Grant to American Society of Nephrology Kidney Week (from Australian New Zealand Society of Nephrology). 2015
Publications
Journals
- Francis, A., Neuen, B., See, E., Shah, A., Smyth, B., Tungsanga, S., Viecelli, A., Yeung, E., Arruebo, S., Bello, A., Wong, M., Chen, T., et al (2024). Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney International Supplements, 13(1), 110-122. [More Information]
- Chen, T., Cao, Q., Wang, R., Zheng, G., Azmi, F., Lee, V., Wang, Y., Li, H., Yu, D., Rogers, N., Harris, D., Wang, Y., et al (2023). Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease. Clinical Immunology, 250. [More Information]
- Cao, Q., Wang, R., Niu, Z., Chen, T., Azmi, F., Read, S., Chen, J., Lee, V., Zhou, C., Julovi, S., Zheng, G., George, J., Wang, Y., et al (2023). Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury. JHEP Reports, 5(10), 100837-100837. [More Information]
2024
- Francis, A., Neuen, B., See, E., Shah, A., Smyth, B., Tungsanga, S., Viecelli, A., Yeung, E., Arruebo, S., Bello, A., Wong, M., Chen, T., et al (2024). Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney International Supplements, 13(1), 110-122. [More Information]
2023
- Chen, T., Cao, Q., Wang, R., Zheng, G., Azmi, F., Lee, V., Wang, Y., Li, H., Yu, D., Rogers, N., Harris, D., Wang, Y., et al (2023). Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease. Clinical Immunology, 250. [More Information]
- Cao, Q., Wang, R., Niu, Z., Chen, T., Azmi, F., Read, S., Chen, J., Lee, V., Zhou, C., Julovi, S., Zheng, G., George, J., Wang, Y., et al (2023). Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury. JHEP Reports, 5(10), 100837-100837. [More Information]
2021
- Chen, T., Cao, Q., Wang, R., Zheng, G., Azmi, F., Wang, J., Lee, V., Wang, Y., Yu, H., Patel, M., Rogers, N., Wang, Y., Harris, D., et al (2021). Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations. Frontiers in Immunology, 12, 635212. [More Information]
- Rao, P., Qiao, X., Hua, W., Hu, M., Tahan, M., Chen, T., Yu, H., Ren, X., Cao, Q., Wang, Y., Yang, Y., Lee, V., Harris, D., Zheng, G., et al (2021). Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney Injury. American Journal of Pathology, 191(6), 993-1009. [More Information]
- Yang, Y., Nankivell, B., Hua, W., Rao, P., Ren, X., Yu, H., Chen, T., Cao, Q., Wang, Y., Wang, Y., Lee, V., Rogers, N., Zheng, G., Harris, D., et al (2021). Renal tubular cell binding of β-catenin to TCF1 versus FoxO1 is associated with chronic interstitial fibrosis in transplanted kidneys. American Journal Of Transplantation, 21(2), 727-739. [More Information]
2020
- Cao, Q., Wang, R., Wang, Y., Niu, Z., Chen, T., Wang, C., Jin, L., Huang, Q., Li, Q., Wang, X., Azmi, F., Lee, V., Zheng, G., Harris, D., et al (2020). Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury. Kidney International, 97(1), 130-142. [More Information]
- Chen, T., Wong, N., Visvanathan, S., Kwok, F., Radhakrishnan, J., Harris, D., Vucak-Dzumhur, M. (2020). The Case | A hidden deposit. Kidney International, 97(4), 815-816. [More Information]
2019
- Wang, R., Chen, T., Wang, C., Zhang, Z., Wang, X., Li, Q., Lee, V., Wang, Y., Zheng, G., Alexander, S., Wang, Y., Harris, D., Cao, Q. (2019). Flt3 inhibition alleviates chronic kidney disease by suppressing CD103(+) dendritic cell-mediated T cell activation. Nephrology Dialysis Transplantation, 34(11), 1853-1863. [More Information]
- Chen, T., Cao, Q., Wang, Y., Harris, D. (2019). M2 macrophages in kidney disease: biology, therapies, and perspectives. Kidney International, 95(4), 760-773. [More Information]
- Rao, P., Pang, M., Qiao, X., Yu, H., Wang, H., Yang, Y., Ren, X., Hu, M., Chen, T., Cao, Q., Wang, Y., Khushi, M., Lee, V., Zheng, G., Harris, D., et al (2019). Promotion of β -catenin/Foxo1 signaling ameliorates renal interstitial fibrosis. Laboratory Investigation, 99(11), 1689-1701. [More Information]
2018
- Chen, T., Achan, A., Wong, G. (2018). Acquired cystic disease-associated renal cell carcinoma. Nephrology, 23(7), 704-705. [More Information]
- Chen, T., Achan, A., Li, K., Harris, D. (2018). Collagenofibrotic Glomerulopathy. Nephrology, 23(6), 601-602. [More Information]
- Chen, T., Hassan, H., Qian, P., Vu, M., Makris, A. (2018). High-Sensitivity Troponin T and C-Reactive Protein Have Different Prognostic Values in Hemo- and Peritoneal Dialysis Populations: A Cohort Study. Journal of the American Heart Association, 7(5), e007876. [More Information]
2016
- Chen, T., Cleland, B., Nankivell, B. (2016). The Case | Rapidly progressing polyneuropathy in a dialysis patient. Kidney International, 89(6), 1409-1410. [More Information]
2015
- Chen, T., Harris, D. (2015). Challenges of chronic kidney disease prevention. Medical Journal of Australia, 203(5), 209-210. [More Information]
2012
- Chen, T., McDonald, A., Shadbolt, B., Talaulikar, D. (2012). Precision of histological bone marrow staging in follicular Lymphoma and diffuse large B-cell Lymphoma. Clinical and Investigative Medicine, 35(6), E358-E364.